Skip to content

Dose-response effects of wild blueberries on appetite and cardiovascular health

Effects of wild blueberry on obesity – a pilot dose-response study targeting starch digestion and satiety through activation of gut-brain axis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11726069
Enrollment
24
Registered
2024-11-15
Start date
2023-04-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduction of postprandial glycaemia Nutritional, Metabolic, Endocrine

Interventions

The study is conducted using a counterbalanced crossover trial design, with each participant acting as their own control. Participants will attend the lab on four separate occasions, separated by at l

Sponsors

Wild Blueberry Association of North America
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Between 18 – 56 years of age 2. Body mass index (BMI) <27.0 kg/m2 3. Be in general good health (with no known food allergies/intolerances) 4. Not taking any medication/s known to affect blood pressure, blood glucose (like diabetic medication) or cholesterol 5. Not be pregnant or planning a pregnancy within the next 3 months. Not have been pregnant or lactating within the previous 6 months 6. Not menopausal 7. Like all the study foods and test products (checked at screening) 8. Be a non-smoker (for at least the last 6 months) 9. Sufficient fluency in the English language to be able to understand the study instructions and questionnaires 10. Willing to visit the laboratory for a screening session (1 hour) and 4 test mornings (8.00 am – 12.00 pm)

Exclusion criteria

Exclusion criteria: 1. Age =56 years 2. BMI >27 kg/m2 3. Blood donation 14 units/week of alcohol in women or >21 units/week in men in the last 3 months 6. For women: pregnancy, lactation, perimenopause 7. No access to mobile phone and internet 8. Simultaneous participation in other relevant studies

Design outcomes

Primary

MeasureTime frame
Interstitial glucose measured by continuous glucose monitoring at baseline and every 15 minutes across a 3-hour postprandial period

Secondary

MeasureTime frame
1. Blood pressure measured using an automatic blood pressure monitor at baseline and every 30 minutes 2. Appetite measured using visual analogue scales at baseline and every 30 minutes 3. Incretin hormones measured using venous blood samples from cannulation at baseline and every 30 minutes 4. Cognitive function measured using the Visual Verbal Learning test (VVLT), Corsi Block tapping test (Corsi) and the Rapid Visual Information Processing task (RVIP) at baseline and at 90 minutes after consumption of the drink

Countries

England, United Kingdom

Contacts

Public ContactLucy Ellis
fs15lre@leeds.ac.uk+44 (0)1133437000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026